The weight loss is the highest seen to date among available weight loss drugs
Sources Medically reviewed by: Micheal Seay, MSN, APRN, FNP-BC
With GLP-1 receptor agonists expected to dominate the weight loss market in the near term, several young companies are building on this mechanism, while others are taking a completely different approach
Yes, some patients may use weight loss medication after bariatric surgery, especially if they experience weight regain, increased hunger, or a plateau
Supports recovery: Performance horses and camels may recover more efficiently between efforts
Zepbound (semaglutide) activates GLP-1 receptors throughout the brain and gastrointestinal system, which can influence neurotransmitter activity and potentially affect mood regulation